BioSpace News Archive

Press Releases

Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

March 4, 2026
·
4 min read
Press Releases

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

March 4, 2026
·
9 min read
Press Releases

Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)

March 4, 2026
·
4 min read
Press Releases

Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

March 4, 2026
·
8 min read
Press Releases

CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

March 4, 2026
·
8 min read
Press Releases

MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2

March 4, 2026
·
6 min read
Press Releases

BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

March 4, 2026
·
2 min read
Press Releases

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026

March 4, 2026
·
1 min read
Press Releases

Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform

March 4, 2026
·
2 min read
Press Releases

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

March 4, 2026
·
1 min read